BACKGROUND: Studies have shown that stem cells are directly involved in injury repair, secretion of growth factors to promote wound healing, improvement of blood circulation and promotion of angiogenesis, regulation of immune and inflammation, oxidative resistance, which may be used to treat a variety of chronic diseases.
OBJECTIVE: To review the mechanism of umbilical cord mesenchymal stem cell therapy for metabolic syndrome.
METHODS: A computer-based search of VIP, CNKI and PubMed was performed for articles concerning stem cell transplantation therapy for metabolic syndrome published from January 2004 to October 2014. The search terms were “stem cells, umbilical cord-derived mesenchymal stem cells, stem cells transplantation, metabolic syndrome, insulin resistance, diabetes, hyperlipidemia” in Chinese and English, respectively. Finally, 42 articles were included in result analysis.
RESULTS AND CONCLUSION: Umbilical cord mesenchymal stem cells have the ability of self replication and differentiation, which are ideal seed cells for cell replacement therapy. Meanwhile, umbilical cord mesenchymal stem cells also have paracrine and immunomodulatory functions. Currently, technologies for isolation, culture, identification and in vitro amplification of umbilical cord mesenchymal stem cells are quite mature. Moreover, stem cell transplantation as a new method for the treatment of metabolic syndrome can fundamentally make the target organ damage better as well as improve insulin resistance and glucose and lipid metabolism disorder, which have been proved in animal experiments. However, there are still many clinical problems to be solved.